Commentary: Germany's Pharmaceutical Industry Policies Warn Switzerland

A commentary suggests that Germany's policies, which have led two major pharmaceutical companies to reduce their investments, serve as a cautionary tale for Switzerland regarding the potential for driving away pharmaceutical corporations unnecessarily.